CMCO 250117 30.00P (CMCO250117P30000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

CMCO250117P30000

Watchlist

0.00
0.000.00%

15min DelayTrading Jan 10 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

General Industrial Machinery Stocks Q3 Teardown: Columbus McKinnon (NASDAQ:CMCO) Vs The Rest
Yahoo FinanceJan 9 04:08 ET
The Three-year Shareholder Returns and Company Earnings Persist Lower as Columbus McKinnon (NASDAQ:CMCO) Stock Falls a Further 5.2% in Past Week
Simply Wall StJan 8 05:15 ET
Earnings Tell The Story For Columbus McKinnon Corporation (NASDAQ:CMCO)
Simply Wall StDec 17, 2024 06:38 ET
Columbus McKinnon Donates $15,000 to Habitat for Humanity of the Charlotte Region
PRNewswireDec 12, 2024 09:00 ET
Columbus McKinnon's Innovative Battery-Powered Hoist Named 2024 Product of the Year by Material Handling Product News
Yahoo FinanceDec 10, 2024 09:00 ET
Columbus McKinnon Insiders Added US$1.10m Of Stock To Their Holdings
Simply Wall StNov 25, 2024 05:47 ET

Comments

Moomoo AI

Feb 5, 2024 08:16

Insider's sale of shares at a lower price may suggest belief in the stock's full valuation. However, this is a weak sign and doesn't definitively indicate their view on the stock's value. The lack of insider buying recently and history of sales make us cautious about the stock.

Senior Vice President of Global Product Development & Marketing Mario Ramos Lara Sold A Bunch Of Shares In Columbus McKinnon

Moomoo AI

Jan 4, 2024 11:55

Columbus McKinnon's high P/E compared to the market appears justified due to expected earnings growth and potential EPS increase. This is anticipated to strongly support the share price, barring changes in circumstances.

Getting In Cheap On Columbus McKinnon Corporation (NASDAQ:CMCO) Might Be Difficult

Analysts Notebook

May 27, 2022 08:58

Columns Analysts' screen via BofA, JPMorgan, Morgan Stanley, Mizuho and more

BOFA
• $Oscar Health (OSCR.US)$ BofA analyst Kevin Fischbeck downgraded Oscar Health to Neutral from Buy with a price target of $6, down from $12. The analyst sees greater medical loss ratio uncertainty into 2023. The industry is going to have to manage through the expiration of the expanded Affordable Care Act subsidies, Medicaid redeterminations and the result shift within the risk pool making it more difficult to price, Fischb...

Analysts Notebook

May 26, 2022 05:30

Columns Top upgrades and downgrades on 5/26

Upgrades
• $AmerisourceBergen (ABC.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $182 (from $175)
• $Alignment Healthcare (ALHC.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $14 (from $18)
• $Cigna Group (CI.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $300 (from $265)
• $Canadian National Railway (CNI.US)$ : Evercore ISI Upgrades to Outperform from In Line
• $Youdao (DAO.US)$ : Citic Securities Upgrades to Buy from Neut...